Arthritis Research & Therapy

official impact factor 4.36

Drugs in development: bisphosphonates and metalloproteinase inhibitors

Jon B Catterall and Tim E Cawston*

Arthritis Res Ther 2003, 5:12-24 doi:10.1186/ar604

Accesses  

  • Last 30 days: 69 accesses
  • Last year: 906 accesses
  • All time: 9123 accesses

Cited by

BioMed Central: 1 citation

Research article   Open Access

Mithramycin downregulates proinflammatory cytokine-induced matrix metalloproteinase gene expression in articular chondrocytes

Abdelhamid Liacini, Judith Sylvester, Wen Li, Muhammad Zafarullah Arthritis Research & Therapy 2005, 7:R777-R783 (4 April 2005)